Europe Bioprocessing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)

No. of Pages: 167    |    Report Code: BMIRE00030824    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Bioprocessing Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Bioprocessing Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Bioprocessing Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Chronic Diseases
  • 5.1.2 Growing Biopharmaceutical Industry
5.2 Market Opportunities
  • 5.2.1 Proliferating Demand for Personalized Medicine
5.3 Future Trends
  • 5.3.1 Shift Toward Automated Cell Therapy Manufacturing
5.4 Impact of Drivers and Restraints

6. Europe Bioprocessing Market Regional Analysis

6.1 Europe Bioprocessing Market Overview
6.2 Europe Bioprocessing Market Revenue 2021-2031 (US$ Million)
6.3 Europe Bioprocessing Market Forecast Analysis

7. Europe Bioprocessing Market Analysis – by Product

7.1 Instruments and Consumables & Accessories
  • 7.1.1 Overview
  • 7.1.2 Instruments and Consumables & Accessories: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Bioprocessing Market Analysis – by Scale of Operation

8.1 Commercial Operations and Clinical Operations
  • 8.1.1 Overview
  • 8.1.2 Commercial Operations and Clinical Operations: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

9. Europe Bioprocessing Market Analysis – by Application

9.1 Monoclonal Antibodies
  • 9.1.1 Overview
  • 9.1.2 Commercial Operations and Clinical Operations: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Vaccines
  • 9.2.1 Overview
  • 9.2.2 Commercial Operations and Clinical Operations: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Recombinant Protein
  • 9.3.1 Overview
  • 9.3.2 Commercial Operations and Clinical Operations: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Cell & Gene Therapy
  • 9.4.1 Overview
  • 9.4.2 Commercial Operations and Clinical Operations: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

10. Europe Bioprocessing Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Bioprocessing Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.1.1.1 Europe Bioprocessing Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.1.1 UK: Europe Bioprocessing Market Breakdown, by Product
    • 10.1.1.1.2 UK: Europe Bioprocessing Market Breakdown, by Scale of Operation
    • 10.1.1.1.3 UK: Europe Bioprocessing Market Breakdown, by Application
  • 10.1.1.2 Germany: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Bioprocessing Market Breakdown, by Product
    • 10.1.1.2.2 Germany: Europe Bioprocessing Market Breakdown, by Scale of Operation
    • 10.1.1.2.3 Germany: Europe Bioprocessing Market Breakdown, by Application
  • 10.1.1.3 France: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.3.1 France: Europe Bioprocessing Market Breakdown, by Product
    • 10.1.1.3.2 France: Europe Bioprocessing Market Breakdown, by Scale of Operation
    • 10.1.1.3.3 France: Europe Bioprocessing Market Breakdown, by Application
  • 10.1.1.4 Russia: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Bioprocessing Market Breakdown, by Product
    • 10.1.1.4.2 Russia: Europe Bioprocessing Market Breakdown, by Scale of Operation
    • 10.1.1.4.3 Russia: Europe Bioprocessing Market Breakdown, by Application
  • 10.1.1.5 Italy: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Bioprocessing Market Breakdown, by Product
    • 10.1.1.5.2 Italy: Europe Bioprocessing Market Breakdown, by Scale of Operation
    • 10.1.1.5.3 Italy: Europe Bioprocessing Market Breakdown, by Application
  • 10.1.1.6 Rest of Europe: Europe Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Bioprocessing Market Breakdown, by Product
    • 10.1.1.6.2 Rest of Europe: Europe Bioprocessing Market Breakdown, by Scale of Operation
    • 10.1.1.6.3 Rest of Europe: Europe Bioprocessing Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Bioprocessing Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Getinge AB
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Sartorius AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Corning Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck KGaA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 3M Co
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Eppendorf SE
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Repligen Corp
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Entegris Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Agilent Technologies Inc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Cytiva US LLC.
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. Getinge AB
  2. Thermo Fisher Scientific Inc
  3. Sartorius AG
  4. Corning Inc
  5. Bio-Rad Laboratories Inc
  6. Merck KGaA
  7. 3M Co
  8. Eppendorf SE
  9. Repligen Corp
  10. Entegris Inc
  11. Agilent Technologies Inc
  12. Cytiva US LLC.
europe-bioprocessing-market